We create therapies against viral infections
The emergence of the extremely aggressive influenza strains, as well as recent outbreaks of Zika and Ebola viruses, has made the likelihood of the human pandemics a major worldwide concern. It has also emphasized the need for new therapeutic strategies to combat these pathogens. We employ rational structure-based design of small molecule inhibitors/modulators for diverse molecular targets. Our drug candidates are expected to provide safe and potent alternative to currently utilized antiviral approaches.